FT. MYERS, Fla.,
Dec. 5, 2011
/PRNewswire/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM
announced today that it will present at the 4th Annual LD MICRO Growth Conference on
Thursday, December 8, 2011
. The conference will showcase 101 small and microcap growth companies over two days, and is being held at the Luxe Sunset Bel Air Hotel in
, California. Senior executives of attending companies will make presentations to investors on their business strategy and outlook, and one-on-one meetings with interested parties will be arranged during the conference.
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA–certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in
Fort Myers, FL
, NeoGenomics has labs in
and services the needs of pathologists, oncologists, urologists, and hospitals throughout
the United States
. For additional information about NeoGenomics, visit
Interested parties can also access investor relations material from Hawk Associates at
and from Zack's Investment Research at
About LD MICRO:
LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor.